EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity

Sebastian Mielniczuk, Katharina Hoff, Fady Baselious iD, Yunqi Li iD, Jörg Haupenthal, Andreas M Kany, Maria Riedner iD, Holger Rohde, Katharina Rox iD, Anna K H Hirsch iD, Isabelle Krimm iD, Wolfgang Sippl iD und 1 weitere

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c01262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Sebastian Mielniczuk und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic Chemistry, Universität Hamburg, Martin-Luther-King-Platz 6, 20146 Hamburg, Germany. Hauptthemen laut MEDLINE: Amidohydrolases, Anti-Bacterial Agents, Molecular Docking Simulation, Enzyme Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Deutsches Zentrum f?r Infektionsforschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In a fragment-based approach using NMR spectroscopy, benzyloxyacetohydroxamic acid-derived inhibitors of the bacterial deacetylase LpxC bearing a substituent to target the uridine diphosphate-binding site of the enzyme were developed. By appending privileged fragments via a suitable linker, potent LpxC inhibitors with promising antibacterial activities could be obtained, like the one-digit nanomolar LpxC inhibitor (S)-13j [Ki (EcLpxC C63A) = 9.5 nM; Ki (PaLpxC): 5.6 nM]. To rationalize the observed structure-activity relationships, molecular docking and molecular dynamics studies were performed. Initial in vitro absorption-distribution-metabolism-excretion-toxicity (ADMET) studies of the most potent compounds have paved the way for multiparameter optimization of our newly developed isoserine-based amides.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmidohydrolasesAnti-Bacterial AgentsMolecular Docking SimulationEnzyme InhibitorsStructure-Activity RelationshipMicrobial Sensitivity TestsMolecular Dynamics SimulationHydroxamic AcidsHumansAnimals

Substanzen

AmidohydrolasesAnti-Bacterial AgentsEnzyme InhibitorsHydroxamic AcidsLpxC deacetylase, PseudomonasUDP-3-O-acyl-N-acetylglucosamine deacetylase

Autor:innen und Institutionen

  • Institute of Organic Chemistry, Universität Hamburg, Martin-Luther-King-Platz 6, 20146 Hamburg, Germany.
  • German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, 20146 Hamburg, Germany.
  • Institute of Pharmacy, Martin-Luther-University of Halle-Wittenberg, Kurt-Mothes-Straße 3, 06120 Halle (Saale), Germany.
  • Team "Small Molecules for Biological Targets", Institut Convergence Plascan, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon…
  • Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences & School of Life Sciences, East China Normal University, 200241 Shanghai, China.
  • Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Campus E8.1, 66123 Saarbrücken, Germany.

ORCID-Profile: Fady Baselious, Yunqi Li, Maria Riedner, Katharina Rox, Anna K H Hirsch, Isabelle Krimm, Wolfgang Sippl, Ralph Holl

Förderung

  • Deutsche Forschungsgemeinschaft
  • Deutsches Zentrum f?r Infektionsforschung

Zitieren

APA

Mielniczuk, S., Hoff, K., Baselious, F., Li, Y., Haupenthal, J., Kany, A. M., Riedner, M., Rohde, H., Rox, K., Hirsch, A. K. H., Krimm, I., Sippl, W., & Holl, R. (2024). Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01262

Vancouver

Mielniczuk S, Hoff K, Baselious F, Li Y, Haupenthal J, Kany AM, et al. Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01262

BibTeX
@article{Mielniczuk2024,
  author = {Mielniczuk, Sebastian and Hoff, Katharina and Baselious, Fady and Li, Yunqi and Haupenthal, Jörg and Kany, Andreas M and Riedner, Maria and Rohde, Holger and Rox, Katharina and Hirsch, Anna K H and Krimm, Isabelle and Sippl, Wolfgang and Holl, Ralph},
  title = {Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c01262}
}
Kostenlos starten →